{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T05:59:32Z","timestamp":1721368772179},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:00:00Z","timestamp":1413936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00432-014-1857-2","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:05:08Z","timestamp":1413936308000},"page":"877-885","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"141","author":[{"given":"Claudia","family":"Seifert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Wittig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Gruhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,22]]},"reference":[{"issue":"1","key":"1857_CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","volume":"32","author":"CC Barker","year":"2003","unstructured":"Barker CC, Butzner JD, Anderson RA, Brant R, Sauve RS (2003) Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transpl 32(1):79\u201387","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"1857_CR2","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1182\/blood-2008-04-149682","volume":"112","author":"I Benimetskaya","year":"2008","unstructured":"Benimetskaya I, Wu S, Voskresensky AM, Echart C, Zhou JF, Shin J et al (2008) Angiogenesis alteration by defibrotide: implications for its mechanism of action in severe hepatic veno-occlusive disease. Blood 112(10):4343\u20134352","journal-title":"Blood"},{"issue":"7","key":"1857_CR3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/pbc.20934","volume":"48","author":"SR Bulley","year":"2007","unstructured":"Bulley SR, Strahm B, Doyle J, Dupuis LL (2007) Defibrotide for the treatment of hepatic veno-occlusive disease in children. Pediatr Blood Cancer 48(7):700\u2013704","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"1857_CR4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","volume":"17","author":"E Carreras","year":"2011","unstructured":"Carreras E, D\u00edaz-Bey\u00e1 M, Rosi\u00f1ol L, Mart\u00ednez C, Fern\u00e1ndez-Avil\u00e9s F, Rovira M (2011) The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transpl 17(11):1713\u20131720","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"1857_CR5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","volume":"10","author":"Y Chalandon","year":"2004","unstructured":"Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P et al (2004) Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transpl 10(5):347\u2013354","journal-title":"Biol Blood Marrow Transpl"},{"issue":"4","key":"1857_CR6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","volume":"111","author":"R Chopra","year":"2000","unstructured":"Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C et al (2000) Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol 111(4):1122\u20131129","journal-title":"Br J Haematol"},{"issue":"2","key":"1857_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","volume":"16","author":"JA Coppell","year":"2010","unstructured":"Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A et al (2010) Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transpl 16(2):157\u2013168","journal-title":"Biol Blood Marrow Transpl"},{"issue":"8","key":"1857_CR8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bmt.1705485","volume":"38","author":"S Corbacioglu","year":"2006","unstructured":"Corbacioglu S, H\u00f6nig M, Lahr G, St\u00f6hr S, Berry G, Friedrich W et al (2006) Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide. Bone Marrow Transpl 38(8):547\u2013553","journal-title":"Bone Marrow Transpl"},{"issue":"9823","key":"1857_CR9","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","volume":"379","author":"S Corbacioglu","year":"2012","unstructured":"Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A et al (2012) Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet 379(9823):1301\u20131309","journal-title":"Lancet"},{"issue":"4","key":"1857_CR10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","volume":"163","author":"FL Dignan","year":"2013","unstructured":"Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A et al (2013) BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol 163(4):444\u2013457","journal-title":"Br J Haematol"},{"issue":"3","key":"1857_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MPH.0b013e3182427575","volume":"34","author":"L Elbahlawan","year":"2012","unstructured":"Elbahlawan L, McArthur J, Quasney MW, Pei D, Srivastava K, Dahmer MK et al (2012) Association of IL-1\u03b2-511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 34(3):175\u2013179","journal-title":"J Pediatr Hematol Oncol"},{"key":"1857_CR12","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the sub-distribution of a competing risk. JASA 94:496\u2013509","journal-title":"JASA"},{"issue":"3","key":"1857_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14712598.2012.657623","volume":"12","author":"T Guglielmelli","year":"2012","unstructured":"Guglielmelli T, Bringhen S, Palumbo A (2012) Update on the use of defibrotide. Expert Opin Biol Ther 12(3):353\u2013361","journal-title":"Expert Opin Biol Ther"},{"issue":"12","key":"1857_CR14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bmt.1701506","volume":"22","author":"S Hasegawa","year":"1998","unstructured":"Hasegawa S, Horibe K, Kawabe T, Kato K, Kojima S, Matsuyama T, Hirabayashi N (1998) Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors. Bone Marrow Transpl 22(12):1191\u20131197","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"1857_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1705899","volume":"41","author":"VT Ho","year":"2008","unstructured":"Ho VT, Revta C, Richardson PG (2008) Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transpl 41(3):229\u2013237","journal-title":"Bone Marrow Transpl"},{"issue":"8","key":"1857_CR16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/bmt.2009.349","volume":"45","author":"SH Lee","year":"2010","unstructured":"Lee SH, Yoo KH, Sung KW, Koo HH, Kwon YJ, Kwon MM et al (2010) Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Bone Marrow Transpl 45(8):1287\u20131293","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"1857_CR17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clpt.2006.07.002","volume":"80","author":"L Lennard","year":"2006","unstructured":"Lennard L, Richards S, Cartwright CS, Mitchell C, Lilleyman JS, Vora A et al (2006) The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia. Clin Pharmacol Ther 80(4):375\u2013383","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1857_CR18","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood-2009-03-212282","volume":"114","author":"SC Maradei","year":"2009","unstructured":"Maradei SC, Maiolino A, de Azevedo AM, Colares M, Bouzas LF, Nucci M (2009) Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 114(6):1270\u20131275","journal-title":"Blood"},{"issue":"5","key":"1857_CR19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.leukres.2006.07.005","volume":"31","author":"JM McKoy","year":"2007","unstructured":"McKoy JM, Angelotta C, Bennett CL, Tallman MS, Wadleigh M, Evens AM et al (2007) Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leuk Res 31(5):599\u2013604","journal-title":"Leuk Res"},{"issue":"4","key":"1857_CR20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/1078-0432.CCR-08-1270","volume":"15","author":"CS Mitsiades","year":"2009","unstructured":"Mitsiades CS, Rouleau C, Echart C, Menon K, Teicher B, Distaso M et al (2009) Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias. Clin Cancer Res 15(4):1210\u20131221","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1857_CR21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1517\/14712590903008507","volume":"9","author":"F Morabito","year":"2009","unstructured":"Morabito F, Gentile M, Gay F, Bringhen S, Mazzone C, Vigna E et al (2009) Insights into defibrotide: an updated review. Expert Opin Biol Ther 9(6):763\u2013772","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"1857_CR22","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1038\/sj.leu.2404821","volume":"21","author":"O Ostrovsky","year":"2007","unstructured":"Ostrovsky O, Korostishevsky M, Levite I, Leiba M, Galski H, Vlodavsky I et al (2007) Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies. Leukemia 21(11):2296\u20132303","journal-title":"Leukemia"},{"issue":"2","key":"1857_CR23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1189\/jlb.1208735","volume":"86","author":"O Ostrovsky","year":"2009","unstructured":"Ostrovsky O, Korostishevsky M, Shafat I, Mayorov M, Ilan N, Vlodavsky I et al (2009) Inverse correlation between HPSE gene single nucleotide polymorphisms and heparanase expression: possibility of multiple levels of heparanase regulation. J Leukoc Biol 86(2):445\u2013455","journal-title":"J Leukoc Biol"},{"issue":"11","key":"1857_CR24","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2009-08-236455","volume":"115","author":"O Ostrovsky","year":"2010","unstructured":"Ostrovsky O, Shimoni A, Rand A, Vlodavsky I, Nagler A (2010) Genetic variations in the heparanase gene (HPSE) associate with increased risk of GvHD following allogenic stem cell transplantation: effect of discrepancy between recipients and donors. Blood 115(11):2319\u20132328","journal-title":"Blood"},{"issue":"4","key":"1857_CR25","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1542\/peds.2005-1789","volume":"117","author":"M Ouach\u00e9e-Chardin","year":"2006","unstructured":"Ouach\u00e9e-Chardin M, Elie C, de Saint Basile G, Le Deist F, Mahlaoui N, Picard C et al (2006) Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics 117(4):e743\u2013e750","journal-title":"Pediatrics"},{"issue":"9","key":"1857_CR26","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00007890-200211150-00018","volume":"74","author":"R Pihusch","year":"2002","unstructured":"Pihusch R, Salat C, Schmidt E, G\u00f6hring P, Pihusch M, Hiller E et al (2002) Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 74(9):1303\u20131309","journal-title":"Transplantation"},{"issue":"9823","key":"1857_CR27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(12)60067-1","volume":"379","author":"U Platzbecker","year":"2012","unstructured":"Platzbecker U, Bornh\u00e4user M (2012) SOS for veno-occlusive disease: defibrotide prophylaxis. Lancet 379(9823):1277\u20131278","journal-title":"Lancet"},{"issue":"4","key":"1857_CR28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/pbc.21425","volume":"50","author":"A Qureshi","year":"2008","unstructured":"Qureshi A, Marshall L, Lancaster D (2008) Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children. Pediatr Blood Cancer 50(4):831\u2013832","journal-title":"Pediatr Blood Cancer"},{"issue":"3\u20134","key":"1857_CR29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10428199809059219","volume":"31","author":"P Richardson","year":"1998","unstructured":"Richardson P, Bearman SI (1998) Prevention and treatment of hepatic venoocclusive disease after high-dose cytoreductive therapy. Leuk Lymphoma 31(3\u20134):267\u2013277","journal-title":"Leuk Lymphoma"},{"issue":"13","key":"1857_CR30","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D et al (2002) Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 100(13):4337\u20134343","journal-title":"Blood"},{"issue":"7","key":"1857_CR31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","volume":"16","author":"PG Richardson","year":"2010","unstructured":"Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J et al (2010) Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transpl 16(7):1005\u20131017","journal-title":"Biol Blood Marrow Transpl"},{"issue":"3","key":"1857_CR32","first-page":"1831","volume":"26","author":"O Ringd\u00e9n","year":"1994","unstructured":"Ringd\u00e9n O, Ruutu T, Remberger M, Nikoskelainen J, Volin L, Vindel\u00f8v L et al (1994) A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies. Transpl Proc 26(3):1831\u20131832","journal-title":"Transpl Proc"},{"issue":"3","key":"1857_CR33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/leu.2008.323","volume":"23","author":"V Rocha","year":"2009","unstructured":"Rocha V, Porcher R, Fernandes JF, Filion A, Bittencourt H, Silva W Jr et al (2009) Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia. Leukemia 23(3):545\u2013556","journal-title":"Leukemia"},{"issue":"8","key":"1857_CR34","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.bmt.1701994","volume":"24","author":"HC Toh","year":"1999","unstructured":"Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR (1999) Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation. Bone Marrow Transpl 24(8):891\u2013895","journal-title":"Bone Marrow Transpl"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1857-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1857-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1857-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:40:51Z","timestamp":1559068851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1857-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,22]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1857"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1857-2","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,22]]}}}